Pro Medicus’ (ASX:PME) Attractive Earnings Are Not All Good News For Shareholders

Simply Wall St

Wed, February 18, 2026 at 2:24 PM GMT+9 3 min read

In this article:

PMCUF

-24.26%

PMDIY

-17.63%

Investors were disappointed with Pro Medicus Limited’s (ASX:PME) recent earnings release. Our analysis found several concerning factors in the earnings report beyond the strong statutory profit number.

This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality.

ASX:PME Earnings and Revenue History February 18th 2026

Zooming In On Pro Medicus’ Earnings

In high finance, the key ratio used to measure how well a company converts reported profits into free cash flow (FCF) is the accrual ratio (from cashflow). The accrual ratio subtracts the FCF from the profit for a given period, and divides the result by the average operating assets of the company over that time. This ratio tells us how much of a company’s profit is not backed by free cashflow.

As a result, a negative accrual ratio is a positive for the company, and a positive accrual ratio is a negative. While having an accrual ratio above zero is of little concern, we do think it’s worth noting when a company has a relatively high accrual ratio. To quote a 2014 paper by Lewellen and Resutek, “firms with higher accruals tend to be less profitable in the future”.

For the year to December 2025, Pro Medicus had an accrual ratio of 1.11. That means it didn’t generate anywhere near enough free cash flow to match its profit. As a general rule, that bodes poorly for future profitability. To wit, it produced free cash flow of AU$120m during the period, falling well short of its reported profit of AU$234.7m. At this point we should mention that Pro Medicus did manage to increase its free cash flow in the last twelve months Having said that, there is more to the story. The accrual ratio is reflecting the impact of unusual items on statutory profit, at least in part.

Check out our latest analysis for Pro Medicus

That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.

How Do Unusual Items Influence Profit?

Given the accrual ratio, it’s not overly surprising that Pro Medicus’ profit was boosted by unusual items worth AU$149m in the last twelve months. While we like to see profit increases, we tend to be a little more cautious when unusual items have made a big contribution. When we crunched the numbers on thousands of publicly listed companies, we found that a boost from unusual items in a given year is often not repeated the next year. Which is hardly surprising, given the name. Pro Medicus had a rather significant contribution from unusual items relative to its profit to December 2025. All else being equal, this would likely have the effect of making the statutory profit a poor guide to underlying earnings power.

Story Continues  

Our Take On Pro Medicus’ Profit Performance

Summing up, Pro Medicus received a nice boost to profit from unusual items, but could not match its paper profit with free cash flow. For all the reasons mentioned above, we think that, at a glance, Pro Medicus’ statutory profits could be considered to be low quality, because they are likely to give investors an overly positive impression of the company. If you’d like to know more about Pro Medicus as a business, it’s important to be aware of any risks it’s facing. While conducting our analysis, we found that Pro Medicus has 1 warning sign and it would be unwise to ignore it.

In this article we’ve looked at a number of factors that can impair the utility of profit numbers, and we’ve come away cautious. But there is always more to discover if you are capable of focussing your mind on minutiae. Some people consider a high return on equity to be a good sign of a quality business. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks with significant insider holdings to be useful.

Have feedback on this article? Concerned about the content? Get in touch** with us directly.**_ Alternatively, email editorial-team (at) simplywallst.com._

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Terms and Privacy Policy

Privacy Dashboard

More Info